Share on StockTwits

Acceleron Pharma (NASDAQ:XLRN) CFO Kevin F. Mclaughlin unloaded 10,000 shares of Acceleron Pharma stock on the open market in a transaction dated Monday, July 7th. The stock was sold at an average price of $31.72, for a total value of $317,200.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.

Shares of Acceleron Pharma (NASDAQ:XLRN) traded up 4.03% on Wednesday, hitting $30.21. 166,640 shares of the company’s stock traded hands. Acceleron Pharma has a 52 week low of $16.78 and a 52 week high of $57.89. The stock’s 50-day moving average is $32.33 and its 200-day moving average is $38.69. The company’s market cap is $950.3 million.

Acceleron Pharma (NASDAQ:XLRN) last posted its quarterly earnings results on Thursday, May 15th. The company reported ($0.30) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.44) by $0.14. The company had revenue of $3.31 million for the quarter, compared to the consensus estimate of $2.85 million. Analysts expect that Acceleron Pharma will post $-1.24 EPS for the current fiscal year.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.